IPA CEO charged for selling unregistered drugs to the GPHC – Royston Drakes Production
Most Popular Articles

IPA CEO charged for selling unregistered drugs to the GPHC

5 years ago

The head of a local pharmaceutical company was today charged with selling an unregistered drug to the public hospital.

 

Lloyd Singh, Chief Executive Officer of the International Pharmaceutical Company appeared in the Georgetown Magistrates’ Court before Magistrate Judy Latchman, where the charge was read to him. Singh was charged with selling the drug Rituximab.

 

The medication is an unregistered drug and is used to treat Non-Hodgkin’s Lymphoma, Chronic Lymphocytic Leukaemia and other ailments such as Rheumatoid Arthritis. The businessman whose address was given as Lot 226 ‘B’ Camp Street, on August 12, 2017, allegedly sold and supplied the unregistered drug, Rituximab 100MG/10ML to the GPHC. There are reports that the sale is in violation of the Food and Drug Regulation.

 

The businessman was released on $30,000 bail. He will make his next court on  July 27.

Comments

Comments

Comments are closed.